These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3144827)

  • 1. Follow-up of the antibody response to measles vaccine in a rural area of Guinea-Bissau.
    Smedman L; Gunnlaugsson G; Norrby E; Silva MC; Zetterström R
    Acta Paediatr Scand; 1988 Nov; 77(6):885-9. PubMed ID: 3144827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia.
    Smedman L; Silva MC; Gunnlaugsson G; Norrby E; Zetterstrom R
    Ann Trop Paediatr; 1986 Jun; 6(2):149-53. PubMed ID: 2425725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
    Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.
    Aaby P; Lisse IM; Whittle H; Knudsen K; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Epidemiol Infect; 1994 Apr; 112(2):413-20. PubMed ID: 8150016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of age.
    Aaby P; Andersen M; Sodemann M; Jakobsen M; Gomes J; Fernandes M
    BMJ; 1993 Nov; 307(6915):1308-11. PubMed ID: 8257884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries.
    Aaby P; Samb B; Simondon F; Seck AM; Knudsen K; Whittle H
    BMJ; 1995 Aug; 311(7003):481-5. PubMed ID: 7647643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of vitamin A supplementation on measles-specific antibody levels in Guinea-Bissau.
    Benn CS; Balde A; George E; Kidd M; Whittle H; Lisse IM; Aaby P
    Lancet; 2002 Apr; 359(9314):1313-4. PubMed ID: 11965280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The problem of measles virus response with reference to vaccine viability, age, protein energy malnutrition and malaria in the tropics.
    Kimati VP; Loretu K; Munube GM; Kimboi F
    J Trop Pediatr; 1981 Aug; 27(4):205-9. PubMed ID: 6793733
    [No Abstract]   [Full Text] [Related]  

  • 14. Chloroquine treatment of malaria does not increase antibody response to measles vaccination. A controlled study of 580 rural children living in an endemic malaria area.
    Cénac A; Develoux M; Djibo A
    Trans R Soc Trop Med Hyg; 1988; 82(3):405. PubMed ID: 3068857
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of live measles and yellow fever vaccines and inactivated pentavalent vaccines is associated with increased mortality compared with measles and yellow fever vaccines only. An observational study from Guinea-Bissau.
    Fisker AB; Ravn H; Rodrigues A; Østergaard MD; Bale C; Benn CS; Aaby P
    Vaccine; 2014 Jan; 32(5):598-605. PubMed ID: 24325827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression after measles vaccination.
    Smedman L; Joki A; da Silva AP; Troye-Blomberg M; Aronsson B; Perlmann P
    Acta Paediatr; 1994 Feb; 83(2):164-8. PubMed ID: 8193495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau.
    Rasmussen SM; Biering-Sørensen S; Byberg S; Andersen A; Bjerregaard-Andersen M; Rodrigues A; Benn CS; Martins CL; Aaby P
    BMC Pediatr; 2016 Dec; 16(1):199. PubMed ID: 27912735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinated children get milder measles infection: a community study from Guinea-Bissau.
    Aaby P; Bukh J; Leerhøy J; Lisse IM; Mordhorst CH; Pedersen IR
    J Infect Dis; 1986 Nov; 154(5):858-63. PubMed ID: 3772165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.